The Future Cardia offering is now closed and is no longer accepting investments.

Future Cardia

Voice of the Heart

Future Cardia

Voice of the Heart

Houston, TX
Biotechnology
Data/Analytics
We are Future Cardia (Oracle Health, Inc.) - Bringing you a tiny insertable cardiac monitor for a long-term heart failure monitoring solution to disrupt the $5B market and to set the stage for Connected Implants. Our approach is a simple 2-minute office procedure that brings simplicity, accuracy, high compliance for long-term monitoring, and existing insurance coverage.

$3,133,617

raised
$3,289,558
previously crowdfunded
2,364
Investors
$20M
Valuation
$2.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$4.71M
Offering Max
0
Days Left

$3,133,617

raised
$3,289,558
previously crowdfunded
2,364
Investors
$20M
Valuation
$2.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$4.71M
Offering Max
0
Days Left
This offering ended on June 21, 2022 and is no longer accepting investments.
Offering Circular Supplement  Risks Related to this Offering |  SEC EDGAR Filings

Reasons to Invest



  • World-renowned cardiologists, engineers and scientists: with over 180 years of combined expertise in cardiology and medical devices development with multiple exits and one IPO. 
  • Raised $4M ($3.3m on Republic and $700K from Super Angels) in 2021 to disrupt the $5B Heart Failure monitoring market. 
  • Stanford StartX: is the premier accelerator program in the world with one of the highest success rates along with 10 startups achieving unicorn status in the past 12 years. StartX companies have a combined valuation of over $30B and 92% survival rate. Over 300 Silicon Valley mentors participate in the program.
  • Johnson and Johnson's JLABS: is a global network of open innovation ecosystems, enabling and empowering innovators to accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS companies have a combined valuation of $9.4B. Five IPOs, Eight acquisitions.



OVERVIEW


Cardiologist and Patients Deserve a Better Option

Cardiologists today lack good options for monitoring their heart failure patients at home. Future Cardia is developing an implanted remote cardiac monitor to address this problem. Designed to provide comprehensive data and analysis to doctors, Future Cardia also aims to build the largest collection of long-term cardiac data to improve the lives of patients. 

  • Detects early signs of Heart Failure problems before symptoms
  • Pre-clinical testing with 26 heart failure patients
  • Preparing for lab testing and then human implant in 2022 using Electrocardiogram (ECG) and heart sounds with remote monitoring technology to monitor heart
  • Provides actionable and quantifiable data analytics for the cardiologists

THE PROBLEM


Heart Failure Emergencies are a $21 Billion a Year Problem


A lack of remote Heart Failure monitoring solutions makes it difficult for heart failure patients and healthcare providers to address emergencies. As a chronic disease, our patients and physicians are stuck between real emergencies and false alarms, resulting in referral to the Emergency Department and subsequent admission to the hospital, even if it is a false alarm.   



Heart failure is a cardiac condition that often results in breathing problems and frequent hospitalizations. Heart Failure patients have weakened heart muscles. As the heart begins to fail, fluid slowly accumulates in the lungs, which can lead to sudden and severe breathing problems.


In the US alone, six million patients suffer from Heart Failure. Canada and Europe are facing the same problem. Because of the lack of a remote monitoring solution for Heart Failure, patients are referred to the ER and subsequently hospitalized, even if it is a false alarm.


Invasive heart procedure devices such as CardioMems by Abbott (acquired for $455 million) are the current standard. This device requires a sensor implant inside the heart or around the heart (Pulmonary Artery) in a cath lab procedure. Accurate, however, they are expensive, complex and are not the ideal solution for all patients.


Wearable monitors are ideal for short-term solutions, however, they suffer from low accuracy, patient non-compliance, and limited data. Therefore, they have a limited use when it comes to long-term Heart Failure monitoring.


THE market



$5 Billion Total Addressable Market Opportunity

Initially, Future Cardia will focus on the one million patients suffering from heart failure, who are in immediate need of remote monitoring solutions. Eventually we hope to reach all six million Americans who suffer from heart failure.

THE solution


A Cardiac Monitor Using Remote Monitoring Technology and AI


Future Cardia is developing a tiny, insertable cardiac device to monitor Heart Failure and reduce unnecessary hospitalizations. The device utilizes multi-sensors, remote monitoring technology and cloud based Artificial Intelligence for long-term comprehensive cardiac monitoring. 


This is a simple 2-minute office procedure that does not require a follow up, saving time for both patients and cardiologists. The device is inserted under the skin for improved accuracy, and does not require invasive surgery that other implanted devices do.    





By tracking trends in ECG and Heart Sounds readings, physicians can detect heart failure decompensation before the onset of symptoms. This gives them actionable data to steer the patient away from further complications.  


Billions of data points for a comprehensive long term cardiac monitoring solution


Future Cardia is developing a compact cardiac device that is inserted subcutaneously (under the skin) in a two-minute office procedure. Once administered, each device yields billions of data points, allowing healthcare providers to compare trending changes over 2-3 years for continuous cardiac monitoring. As Future Cardia collects more data, the analysis will improve through the use of machine learning and AI using ECG and Heart Sounds as biomarker for Cardiology.


Our product relies on three main features: an acoustic sensor, an ECG, and a 3-Axis Accelerometer. The acoustic sensor listens to heart and lung sounds, while the Electrocardiogram (ECG) records heart rhythms and 3-Axis Accelerometer records activity, posture and body orientation.


Our device has high patient compliance over the long-term, because patients do not need to follow a complex process to monitor their cardiac health.


Recorded cardiac data is securely transmitted to a smartphone, then to a cloud-based Artificial Intelligence algorithm for analysis, which the cardiologist can then review and take action.


By analyzing electrical and physiological trends, Future Cardia detects early signs of cardiac decline even before symptoms appear. This allows clinicians to prioritize at-risk patients, implement therapeutic interventions, and prevent hospitalizations. 



why invest


Short Regulatory Path with Existing Insurance Coverage of $7,400 / Device for Commercialization 






Future Cardia has a simple go-to-market plan. First, we will focus on two highest volume regions, Texas and Florida. We expect Texas and Florida to generate $5.5 million within two years of launch. Each unit will retail for $5,300/unit with an established reimbursement of $7,400 (insurance coverage). With this business model, we project that our first 5K implants will generate $26M in revenue within 4 years. 


Second, we will obtain the most comprehensive, long-term cardiac data to date as biomarkers for cardiology. This will allow Future Cardia to venture into predictions for cardiac events, and human longevity study.  


AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT.

THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT CAN BE FOUND HERE [https://www.sec.gov/Archives/edgar/data/1777274/000121390021002171/ea133381-253g1_oraclehealth.htm].

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.


Future Cardia 17b Disclosure

Insert Image
Drop image
(or click)

Loading image

In the Press

Space Florida

Space Florida, Florida Venture Forum Announce Award Winners from 2021 Florida Early Stage Capital Conference and Statewide Collegiate Startup Competition

Florida Venture Forum

2021 Early Stage Capital Conference

St. Pete Catalyst

Medical device startup raises nearly $1M via crowdfunding campaign

Tampa Bay Wave

Congratulations to Jaeson Bang of Oracle Health for being awarded $20K at the 2021 Florida Early Stage Capital Conference, held by Space Florida and the Florida Venture Forum!

Tech Nori

Oracle Health's tiny, non-invasive heart monitor is one-of-a-kind | Technori Pitch

Updates

Less than 24 Hours Left

4 months ago


Hello StartEngine Investor Community. 

We are getting close to finalizing our offer. 

And huge thanks to our investors, we have raised over $2.9M on StartEngine. 

If our investors add an additional $250, then we can reach well over $3M. 

Your investment is allowing us to be scrappy and fast! Will stay vigilant for our patients, physicians and you the investor! 

Please help us finish this offering strong!! 

Thank you. 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

Final Hours to Invest

4 months ago


Hello StartEngine Investor Community. 

We are getting close to finalizing our offer. 

And huge thanks to our investors, we have raised over $2.8M on StartEngine. 

If our investors add an additional $250, then we can reach well over $3M. 

Your investment is allowing us to be scrappy and fast! Will stay vigilant for our patients, physicians and you the investor! 

Please help us finish this offering strong!! 

Thank you. 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

48 Hours Remaining - Let's finish strong

4 months ago




Hello StartEngine Investor Community. 

We are getting close to finalizing our offer. 

And huge thanks to our investors, we have raised over $2.8M on StartEngine. 

If our investors add an additional $250, then we can reach well over $3M. 

Your investment is allowing us to be scrappy and fast! Will stay vigilant for our patients, physicians and you the investor! 

Please help us finish this offering strong!! 

Thank you. 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

Final 3 Days Remaining

4 months ago


Hello StartEngine Investor Community. 

We are getting close to finalizing our offer to our investors. 

And huge thanks to so many of our investors that have invested again. We have raised over $2.7M from investors like you. 

If our investors add an additional $250, then we can reach well over $3M. 

Please help us finish this offering strong!! 

Thank you. 


Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

US Patent Office and Future Cardia

4 months ago


Dear Investors, 

We are making solid progress on our Patent Process. 

We are pleased to report that we have now received a Notification from the United States Patent and Trademark Office (USPTO), indicating that our Petition to Convert Application to a Provisional Application has been Granted. 

Thank you so much for your support!! 


Jae B

Implant Update - Future Cardia

4 months ago



Dear StartEngine Investor Community, 

As we reach the final days of offering, I would like to update you on our implant status. 

Our engineering team gathered in to build a beautiful device that will be implanted this week. 

Our algorithm is working very nicely, as we will test for automatic sensing and detection software. 

It will continuously look at the normal rhythm and start to record when it becomes irregular. 

Hugely complex and delicate operation, but we are confident we will achieve it this week. 

All our activities are possible because of you the investor!!

Thank you. 


Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

$2.5M in Investment

4 months ago


Dear StartEngine Investors, 

Thank you so much for your support! 

We have surpassed $2.5 Million in investments from StartEngine investor community. 

-NDA signed with a top medical device company 

-Lab Implant #2 

- Sensing and Detection 

-Human implant on schedule 

-hired regulatory team in US and EU


Thank you and more to follow!! 

Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

Artificial Intelligence and Future Cardia

4 months ago

Dear StartEngine Investors, 

We have analyzed the cardiac data from our lab testing. 

We can see the electrical and mechanical aspects of the heart that is represented by ECG and Heart Sounds. 

And then applied Artificial Intelligence to those data

They are short, but it is a huge step for us to human implant and subsequent data analytics. 

Thank you. 

Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

NDA Signed with a Top Medical Device Company

4 months ago

Dear StartEngine Investor Community, 

Today at Heart Rhythm Society, we have signed a Nondisclosure Agreement (NDA) with one of the biggest med tech companies in the world.

This will allow us to discuss and potentially collaborate that will heighten our presence in Cardiac Devices stage. 

More to follow. 

Thank you. 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

2 Weeks Remaining

4 months ago

Dear StartEngine Investor Community. 

Thank you for your investment in us. 

We would not be here without your support. We have reached the final 14 days before we close the offering. 

Your funding is allowing us to challenge the old guards at our term. 

This allows us to be scrappy, aggressive, and agile.

We believe the current corporations have been sitting on a multi-billion dollar industry with little innovation. 

We hope to change that and bring value to patients, physicians and you the investors.

Thank you. 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

Thank you from Jae

4 months ago


Thank you. 

Three years have gone by in a blink of an eye. 

I left my dream job to pursue my passion. 

A legend in my industry helped me because he believed in me - not with money, but with an endorsement with his name on it. 

A complete stranger helped me with an introduction to a legendary investor - when nobody wanted to use that card.   

Today, we have over 6000 investors that have invested in me! All I could offer was a dream and a passion. And a commitment to our patients, physicians and you the investors. 

So, thank you for your trust in me. 

You are the builders, the supporters, and a believer. You are a Dreamer like me. Grit and passion with a chip on your shoulder. 

Yes, You. The one with the guts to say let's do it, by putting your blood, sweat and tears. 

You are my champion and an inspiration


And I am yours. I will deliver even if this is the last I will ever do. 


Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. 

$2M Raised: 20 Days Remaining to Invest

4 months ago

Dear StartEngine Investors, 

Thank you so much for your support! 

We have surpassed $2 Million in investments from StartEngine investor community. 

It is a huge honor to have this responsibility to over 6000 investors that have invested in Future Cardia. 

We are now in talks with potential strategic investors that will bring huge value to patients and clinicians.

Thank you and more to follow!! 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  

Next Huge Milestone

4 months ago


Dear StartEngine investor community, 

Huge milestone and a challenge for us in June.

We will be implanting a fully capable bioelectric device in the lab on June 14th. 

It is our latest step to human implant as we will be testing our superior wireless technology and sensor capabilities. 


Goal for June 14th: 

-Sensing and detection algorithm 

-finetune wireless capability 

-automate some of the functions. Device > Mobile device > Cloud > Laptop for display 


DATA: 

Our data analytics is nearly completed. However, I cannot share that with you because of the sensitive nature of the data. 

Thank you. 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Recorded Webinar Available

4 months ago


Hello Everyone, 

This is the recorded webinar from May 19, 2022.

Topic: Future Cardia Webinar on StartEngine. 


Link to the Webinar on Youtube


We would welcome your review. 

And please feel free to comment. 

Thank you. 


Jae B

28 Days Left

4 months ago


Dear StartEngine Investor Community. 

Thank you for your investment in us

We would not be here without your support. We have reached the final 28 days before we close the offering. 

Your funding is allowing us to challenge the old guards at our term. 

This allows us to be scrappy, aggressive, and agile.   

We believe the current corporations have been sitting on a multi-billion dollar industry with little innovation. We hope to change that and bring value to patients, physicians and you the investors. 


Thank you. 

Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

16 Unicorns at Stanford StartX

5 months ago


Dear StartEngine Investor Community, 

I would like to share with you a brief overview of what Stanford StartX is. 

It is one of the most elite accelerators in the world with the highest performance rate. 

Since 2013, StartX community help build 16 unicorns, and many other successful startups. 

It is a huge honor to be a part of this organization... and I would not be here without your support. 

Thank you. 

Jae B


$500K raised in 1 week

5 months ago


Dear StartEngine Investors, 

Thank you for your investment in Future Cardia. 

We raised over $500K in one week to surpass a total of $1.8M in investments.

It is a huge honor to have this responsibility to over 6000 investors that have invested in Future Cardia from the beginning.

Thank you and more to follow!! 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Webinar Next Week - Future Cardia

5 months ago



Dear StartEngine Investors, 

Hope all is well. 

I will be conducting a Webinar to Thank you in person and to showcase our progress. 

Please register and join us on: 

May 19th, 2022 

11 am PST / 2 pm EST

LINK to REGISTER 


Goal of Webinar: 

-Offering Closing Soon. 

-Implant Data 

-Human implant for Dec 2022 

-What's in plan for 2022 


Thank you. 

Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

$1.7M Raised

5 months ago


Dear StartEngine Investors, 

Thank you so much for your support! We have surpassed $1.7 Million in investments from StartEngine investor community. 

It is a huge honor to have this responsibility to over 6000 investors that have invested in Future Cardia. 

We are now in talks with potential strategic investors that will bring huge value to patients and clinicians. 

Thank you and more to follow!! 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  

Florida Venture Forum and Future Cardia

5 months ago

Dear StartEngine Investor Community, 

Huge news for us! 

Future Cardia was selected as one of the startups to pitch at Florida Venture Forum. 

Florida Venture Forum is the largest and most active SEED, Angel and Venture funds organization in Florida. And one of the biggest in the US

Startups participating in Florida Venture Forum have raised total of $11B to date.

https://flventure.org/

Last year, we won $20K in a pitch competition. 

Thank you. 

Jae B

Wilson Sonsini Invite - Future Cardia

5 months ago

Dear StartEngine Investor Community, 

I am proud to announce that Future Cardia will attend Medical Device Conference 2022, hosted by Wilson Sonsini. 

https://mdc.wsgrevents.com/ 

Wilson Sonsini is considered as the premier law firm out of Palo Alto CA. 

They have been guiding and advising high tech startups for the past four decades. 

This event brings the top investors and industry leaders in one place to showcase Future Cardia. 

We look forward to represent your Future Cardia. 

Thank you. 

Jae B

Thank you from your CEO

5 months ago

Dear StartEngine Investors, 

I have been a member of the Heart Rhythm Society for almost 15 years. 

This organization has over 7000 members - top cardiologists, scientists, engineers and industry experts from all over the world. 

These members shape the way we care for patients suffering from cardiac diseases. 

Because of your support, I was able to attend this event and sign two of the key physicians for our operation. 

And to meet with potential investors and strategic partners. 

I am extremely proud that you allowed me to represent your investment. 


Thank you. 

Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. 

NDA signed with a top medical device company

5 months ago



Dear StartEngine Investor Community, 

Today at Heart Rhythm Society, we have signed a Nondisclosure Agreement (NDA) with one of the biggest med tech companies in the world.

This will allow us to discuss and potentially collaborate that will heighten our presence in Cardiac Devices stage. More to follow. 

Thank you. 

Jae B

Offering Ends in 2 months

5 months ago

Dear StartEngine Investor Community. 

Thank you for your investment in us. We would not be here without your support. 

We have reached the final 60 days before we close the offering.

Your funding is allowing us to challenge the old guards at our term. This allows us to be scrappy, aggressive, and agile.  


We believe the current corporations have been sitting on a multi-billion dollar industry with little innovation.

We hope to change that and bring value to patients, physicians and you the investors. 


Thank you.

Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

Surpassing $1,300,000 in Investments

5 months ago


Dear StartEngine Investors, 

Thank you so much for your support! 

We have surpassed $1.3 Million in investments from StartEngine investor community. 

It is a huge honor to have this responsibility to over 6000 investors that have invested in Future Cardia. 

We are now in talks with potential strategic investors that will bring huge value to patients and clinicians. 

Thank you and more to follow!! 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  

Invitation to Heart Rhythm Society

6 months ago


Dear StartEngine Investor Community, 

Future Cardia was invited to attend Heart Rhythm Society (HRS) meeting in San Francisco later this month. 

The Heart Rhythm Society (HRS) is a leading resource on cardiac pacing and electrophysiology. This specialty organization represents more than 7,000 medical, allied health, and science professionals from more than 90 countries who specialize in cardiac rhythm disorders.


https://www.hrsonline.org/


This is a huge honor for us. 

Thank you. 

Jae B

Successful Implant - Future Cardia

6 months ago


Thank you StartEngine Investor Community, 


We had achieved a successful implant last week in a lab. 

We achieved a high level of complexity in a fraction of time and cost, compared to others. 


1. We demonstrated a strong wireless technology 

2. Successfully recorded ECG and Heart Sounds with highest accuracy

3. Wireless Data transmission to an external device, then to cloud computing was successful. 


We will conduct a live webinar to report our findings to our investor later this month. 

Next goal is to finetune and automate most of the functions. 

We will achieve this by June 2022. 


We are well on our way to human implant by Dec 2022. 

Thank you. 

Jae B


Please read the Offering Circular (link) and Risks (link) related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC, member FINRA (link)/SIPC (link).  This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. 

$1,200,000 in Investments - Future Cardia

6 months ago

Dear StartEngine Investors, 

Thank you so much for your support! 

We have surpassed $1.2 Million in investments from StartEngine investor community. 

It is a huge honor to have this responsibility to over 6000 investors that have invested in Future Cardia. 

Our implant data is one of the most comprehensive cardiac data to date. This gives us solid ground and scientific data to reinforce and add to the old data. Next implants will be focusing on automatization of the data recording and flow. 


Human implant in Dec 2022.

 

Thank you and more to follow!! 

Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  

Balance between Technology and Art

6 months ago

Dear StartEngine Community, 

The goal of the implant is to test our wireless technology and recording capabilities. 

As it will be one of the key features of our device. Our device will bring superior connectivity that is secure and reliable.

This is especially important for the implanted bioelectric devices, because the balance between power and size has to be achieved. 

Small - then too weak. 

Powerful - then too big. 


It is a fine balance between engineering and art.

 

More to follow. 

Thank you. 

Jae B

6 days and counting

6 months ago


Dear StartEngine investor community, 

We are 6 days away from a huge milestone. 

We will be implanting a fully capable bioelectric device in the lab. It is our first step to human implant as we will be testing our superior wireless technology and sensor capabilities. 


Recorded data will be transmitted to a laptop and then to a cloud based AI. 

More to follow. 


Thank you.

Jae B

Implant in Two weeks

7 months ago


Dear Investors, 

Great news and a huge milestone for us.

We have a device that is ready to be implanted in the lab. We were able to laser weld the Titanium casing and implantable batteries with fully developed electronics inside. 

This is a temporary device that is able to be water tight for about 24 hours. And this will allow us to test for the most important wireless technology and ECG / Heart Sound recording capabilities we developed. 

We believe our technology is far superior to anything out there and that it will deliver the performance we set forth. 

Thank you for your investment and encouragements. 

More to follow!! 

Jae B

his investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. 

Thank You from your CEO

7 months ago


Thank You StartEngine Community,

I had no idea on the power of the Crowd when we started this journey. Every medical device startup I know has raised funding from Angel Investors and Venture Capitalists. Two startups I worked for did that and they went IPO. So why not do both.

We already had solid financial backing from Angel Investors, and had some deep conversations with Venture Firms.

However, I really liked the idea of Equity Crowdfunding that gave investment opportunities to all investors. It was efficient, transparent, and engaging. And the platform democratized funding for all by leveraging the wisdom of the crowd.

Because of these advantages, I decided to continue with our Investors like YOU on StartEngine. Almost two years into it, I never thought it would lead to a massive movement with over 5,000 investors who have entrusted me with this responsibility.

I will bring value to patients, physicians and you.

Thank you.
Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. 

$1 Million in Investments - Future Cardia

7 months ago




Dear Investors, 

Thank you so much for joining us in this journey! 

We have surpassed $1 Million USD in investments from StartEngine investor community. 

It is a huge honor to have this responsibility to over 5000 investors that have invested in Future Cardia.

We are inspired by your trust in us. We will not let you down. 

Thank you and more to follow!! 


Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.  

Implant in Q1 2022

7 months ago



Dear Investors, 

Our device is ready to be implanted in Vivo in lab setting. 

We are concluding wireless capability at a specialized facility, and our results are sufficient for in Vivo testing. 

We are moving fast and being scrappy with your investment, while bringing the highest quality device that we can be proud of. 


Thank you. 

Jae B

Stanford and Future Cardia

8 months ago


Dear StartEngine Investors, 

Brief update on Stanford StartX and its importance to Future Cardia. 

Stanford StartX is the premier accelerator program in the world with one of the highest success rates, along with 10 startups achieving unicorn status in the past 12 years. 

StartX companies have a combined valuation of over $30B and 92% survival rate. 

Over 300 Silicon Valley mentors participate in the program to create one of the most powerful network of entrepreneurs, professors, scientists, and investors. 

As a startup, there is no other validation that can match this level of caliber. 

Huge honor for us.


Thank you. 

Jae B

$900K Surpassed - Future Cardia

8 months ago

Dear Investors,

Thank you so much for your trust in us. 

We have surpassed $900,000 in investments from StartEngine investor community. 

We were also featured in Angels and Entrepreneurs, as well as KingsCrowd. 

And we are on target for our lab implant for Q1 2022.


Thank you and more to follow!! 

Jae B 

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Device Ready for Testing

8 months ago

 


Hello StartEngine Investors, 

This is a huge milestone for us, and we would not be here with investors like you. 

Our chipset and the board is finally here. You can see the 3D rendering and the actual board. This is an exciting time for us, as we are gearing up for a test implant.

This implant will be a short one to test for functionality and wireless technology.

More to follow. 

Thank you.

Jae B

KingsCrowd and Future Cardia

8 months ago



Dear Investors, 

KingsCrowd analysts conducted a deep conversation with Future Cardia CEO, Jae Bang. 

KingsCrowd is a premier private market ratings and analytics provider. They are a team of financiers, venture capitalists, technologists, founders, and industry experts on a mission to democratize private market investing. 

Here is the link to the interview. 

https://kingscrowd.com/founder-profile-future-cardia-jaeson-bang/


Thank you.

Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Another Milestone for Future Cardia

8 months ago

Dear Investors, 

Thank you so much for your trust in us. 

We have surpassed $800,000 in investments from StartEngine investor community. 

We were also featured in Angels and Entrepreneurs, as well as KingsCrowd. 


More news to follow. 


Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. 

One of the biggest Angel investor Network

8 months ago



Dear Investors, 

Great news. 

Future Cardia is highlighted under the Private Deal Flow section of the Angels and Entrepreneurs network

The Angels & Entrepreneurs Network connects entrepreneurs and investors to support the next wave of revolutionary startups. Established in 2019 by serial entrepreneur and millionaire angel investor Neil Patel.

Angels & Entrepreneurs has grown to over 100,000 subscribers strong.

Thank you. 

Jae B

Future Cardia and Artificial Intelligence Article by an Investor

8 months ago

Hello Everyone, 

We have a nice write up about Future Cardia and Artificial Intelligence by an investor.

Please take a look. 

Link to Article.


Thank you. 

Jae B

Reaching $1M in Investments

8 months ago

Dear StartEngine Investors, 

Thank you so much for your kind consideration on Future Cardia

We set out on this endeavour with a mission to help millions of patients suffering from Irregular Heart beats and Heart Failure problems. 

We would not be here without your support. 

It is an honor to have this responsibility to our patients, physicians and investors.

Thank you. 

Jae B

What is Johnson and Johnson's JLABS?

8 months ago


-$9.4 Billion was secured by JLABS companies 

- Five IPOs 

- Eight acquisitions 

Johnson and Johnson's JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. 

JLABS companies have a combined valuation of $9.4B. Five IPOs, Eight acquisitions. 

Link to JLABS Article.


Thank you. 

Jae B

Recorded Webinar from Jan 13, 2022

8 months ago

Hello Everyone, 

This is the recorded webinar from January 13, 2022.

Topic: Future Cardia Webinar on StartEngine.


Link to the Webinar on Youtube.


We would welcome your review.

And please feel free to comment.

Thank you.
Jae B

What is Stanford StartX and why is it important?

8 months ago


 -10 Startups achieved Unicorn status in 12 years 

- $30Billion raised in total by all StartX companies 

- 92% Survival rate 

- 300 Silicon Valley leaders participate 

Stanford StartX: is the premier accelerator program in the world with one of the highest success rates along with 10 startups achieving unicorn status in the past 12 years. StartX companies have a combined valuation of over $30B and 92% survival rate. Over 300 Silicon Valley mentors participate in the program. 

Link to StartX Twitter 

Link to Accelerator Ranking 

http://seedrankings.com/ 


Thank you.

Jae B

Over 180 Investors are attending our Webinar

9 months ago

Dear SE Investors, 

Over 180 investors have registered for our Town Hall Webinar. 

Please join us on January 13th (Thursday) at 3 pm PST 


Link To Webinar 


Thank you and see you soon. 

Jae B


Town Hall Webinar on Thursday (Jan 13th)

9 months ago

Dear SE Investors, 

Only a day away from our Town Hall Webinar. 

Please join us on January 13th (Thursday). 

Link To Webinar 


Thank you and see you soon. 

Jae B


Town hall Webinar at 3 PM PST on January 13th, 2022.

9 months ago

Dear SE Investors, 

Thank you for your kind consideration on Future Cardia. 

We already surpassed $400K. 

We would like to take this opportunity to conduct a Town Hall webinar to introduce the CEO and conduct a Q&A session with our investors. 

Please join us at 3 PM PST on January 13th (Thursday). 

Please use this link to register. 

Link To Webinar

Thank you and see you in a week. 

Jae B



$377K investments in 15 days

9 months ago

Dear StartEngine Investors. 

Thank you so much for your support in reaching this milestone. 

100% of this investment is from word of mouth

Huge testament to the power of our investors. 

More to follow. 

Jae B


This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

One step closer to human implant

9 months ago

Happy New Year StartEngine Investors, 

Our initial design is completed. 

This will allow us to implant and conduct a short term testing in Q1 2022.

Huge milestone for us.

We are one step closer to human patient implant. 

More to follow. 

Jae B



We surpassed $100K investment in one week

9 months ago

Dear StartEngine Investors, 

Thank you for your kind consideration on Future Cardia and our mission to support millions of patients suffering from chronic heart condition using multi-sensors and a remote monitoring technology. 

We surpassed $100K in investments in less than one week. 

Thank you for your trust in me. 

I take this responsibility seriously as I answer to patients, physicians and investors. 

We will deliver! 

Best, 

Jae B

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Excellent set of questions from a medtech investor

10 months ago

Q: Who is the Incumbent? 

A: Hello Dr. Friedman. Currently, CardioMems by Abbott (acq for $455m) is the current standard. This device requires an implant INSIDE the heart in a cath lab procedure. Accurate, but expensive, complex and suffer from low adoption. 


Q: Why are you better? 

A: We bring a simpler procedure, multi-sensors and remote monitoring capabilities. We have a shorter regulatory process with existing insurance coverage. 


Q: Why not wearables? 

A: Wearables are ideal for short term monitoring. However, they are not used for long term because of low accuracy, non-compliance and limited data. Near zero usage in medical settings. 


Q: What are you measuring? 

A: ECG, Heart Sounds and Activity. Long term trending data for actionable and quantifiable data for cardiologists 

Hope this helps. Thank you. Jae B

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}